Rob Nelissen

498 total citations
15 papers, 410 citations indexed

About

Rob Nelissen is a scholar working on Molecular Biology, Rheumatology and Organic Chemistry. According to data from OpenAlex, Rob Nelissen has authored 15 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Rheumatology and 2 papers in Organic Chemistry. Recurrent topics in Rob Nelissen's work include RNA and protein synthesis mechanisms (6 papers), RNA Research and Splicing (6 papers) and RNA modifications and cancer (4 papers). Rob Nelissen is often cited by papers focused on RNA and protein synthesis mechanisms (6 papers), RNA Research and Splicing (6 papers) and RNA modifications and cancer (4 papers). Rob Nelissen collaborates with scholars based in Netherlands, France and Belgium. Rob Nelissen's co-authors include Walther J. van Venrooij, Cindy L. Will, Reinhard Lührmann, Derick G. Wansink, Luitzen de Jong, Volker Heinrichs, Winand J. Habets, Elma E.M.G. Loomans, Jan T. Keltjens and Servé W. M. Kengen and has published in prestigious journals such as Nucleic Acids Research, The EMBO Journal and The Journal of Immunology.

In The Last Decade

Rob Nelissen

14 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rob Nelissen Netherlands	11	291	63	43	37	28	15	410
Erin E. Witalison United States	9	223 0.8×	153 2.4×	63 1.5×	69 1.9×	21 0.8×	10	435
Matthew Yates United States	8	134 0.5×	20 0.3×	33 0.8×	33 0.9×	24 0.9×	9	252
Roger Santimaria Switzerland	8	238 0.8×	121 1.9×	21 0.5×	69 1.9×	71 2.5×	18	449
Martha B. Reich United States	12	211 0.7×	62 1.0×	11 0.3×	70 1.9×	43 1.5×	15	403
T Seguchi Japan	11	262 0.9×	84 1.3×	16 0.4×	51 1.4×	26 0.9×	16	418
Inne Crèvecoeur Belgium	8	108 0.4×	90 1.4×	22 0.5×	26 0.7×	22 0.8×	9	355
Xijun Ou China	15	340 1.2×	176 2.8×	16 0.4×	49 1.3×	24 0.9×	30	538
Thibault Verjat France	9	222 0.8×	52 0.8×	12 0.3×	107 2.9×	23 0.8×	9	368
H. Yue United States	7	269 0.9×	31 0.5×	14 0.3×	30 0.8×	20 0.7×	15	374
Nadine A. Defranoux United States	10	184 0.6×	92 1.5×	116 2.7×	39 1.1×	9 0.3×	19	385

Countries citing papers authored by Rob Nelissen

Since Specialization

Citations

This map shows the geographic impact of Rob Nelissen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rob Nelissen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rob Nelissen more than expected).

Fields of papers citing papers by Rob Nelissen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rob Nelissen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rob Nelissen. The network helps show where Rob Nelissen may publish in the future.

Co-authorship network of co-authors of Rob Nelissen

This figure shows the co-authorship network connecting the top 25 collaborators of Rob Nelissen. A scholar is included among the top collaborators of Rob Nelissen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rob Nelissen. Rob Nelissen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Moerland, Matthijs, Karen Broekhuizen, U. K. Nässander, et al.. (2020). Proof of pharmacology of Org 48775‐0, a p38 MAP kinase inhibitor, in healthy volunteers. British Journal of Clinical Pharmacology. 87(5). 2321–2332.

Westhovens, René, Ronald van Vollenhoven, DT Boumpas, et al.. (2014). The early clinical course of infliximab treatment in rheumatoid arthritis: results from the REMARK observational study.. PubMed. 32(3). 315–23. 10 indexed citations

Dulos, John, J.A.C. Rullmann, Paul Vink, et al.. (2013). p38 inhibition and not MK2 inhibition enhances the secretion of chemokines from TNF-α activated rheumatoid arthritis fibroblast-like synoviocytes.. PubMed. 31(4). 515–25. 15 indexed citations

Engstrom, Laura, Maria Pinzon-Ortiz, Ying Li, et al.. (2009). Characterization of a murine keyhole limpet hemocyanin (KLH)-delayed-type hypersensitivity (DTH) model: Role for p38 kinase. International Immunopharmacology. 9(10). 1218–1227. 11 indexed citations

Almansa, Carmen, Ruben L. Smeets, Elma E.M.G. Loomans, et al.. (2008). A potent and selective p38 inhibitor protects against bone damage in murine collagen‐induced arthritis: a comparison with neutralization of mouse TNFα. British Journal of Pharmacology. 154(1). 153–164. 46 indexed citations

Samsom, Janneke N., L A van Berkel, Joop M. L. M. van Helvoort, et al.. (2007). Secretory Leukoprotease Inhibitor in Mucosal Lymph Node Dendritic Cells Regulates the Threshold for Mucosal Tolerance. The Journal of Immunology. 179(10). 6588–6595. 37 indexed citations

Zaman, Guido J.R., et al.. (2006). Enzyme Fragment Complementation Binding Assay for p38 α Mitogen-Activated Protein Kinase to Study the Binding Kinetics of Enzyme Inhibitors. Assay and Drug Development Technologies. 4(4). 411–420. 16 indexed citations

Gunnewiek, Jacqueline M. T. Klein, et al.. (1997). Nuclear Accumulation of the U1 snRNP-Specific Protein C Is Due to Diffusion and Retention in the Nucleus. Experimental Cell Research. 235(1). 265–273. 7 indexed citations

Nelissen, Rob, Jacqueline M. T. Klein Gunnewiek, Mark H. L. Lambermon, & Walther J. van Venrooij. (1997). Cloning and characterization of two processed pseudogenes and the cDNA for the murine U1 snRNP-specific protein C. Gene. 184(2). 273–278. 3 indexed citations

10.

Legrain, Pierre, et al.. (1995). Homodimerization of the human U1 snRNP-specific protein C. Nucleic Acids Research. 23(23). 4864–4871. 19 indexed citations

11.

Wansink, Derick G., Rob Nelissen, & Luitzen de Jong. (1994). In vitro splicing of pre-mRNA containing bromouridine. Molecular Biology Reports. 19(2). 109–113. 37 indexed citations

12.

Nelissen, Rob, Cindy L. Will, Walther J. van Venrooij, & Reinhard Lührmann. (1994). The association of the U1-specific 70K and C proteins with U1 snRNPs is mediated in part by common U snRNP proteins.. The EMBO Journal. 13(17). 4113–4125. 107 indexed citations

13.

Nelissen, Rob, et al.. (1991). Structure, chromosomal localization and evolutionary conservation of the gene encoding human U1 snRNP-specific A protein. Gene. 102(2). 189–196. 21 indexed citations

14.

Nelissen, Rob, et al.. (1991). Zinc finger-like structure in U1-specific protein C is essential for specific binding to U1 snRNP. Nucleic Acids Research. 19(3). 449–454. 47 indexed citations

15.

Kengen, Servé W. M., et al.. (1988). Reductive activation of the methyl-tetrahydromethanopterin: coenzyme M methyltransferase from Methanobacterium thermoautotrophicum strain ΔH. Archives of Microbiology. 150(4). 405–412. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact